BioInvent is a startup based in Sweden, most recent round Series B, 3 tracked investors.
Based in Sweden, BioInvent is a startup. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
BioInvent is a clinical-stage biotech company that discovers and develops novel immunomodulatory antibodies for cancer therapy, utilizing its proprietary F.I.R.S.T™ technology platform to identify both targets and antibodies for its clinical pipeline.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.